Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nick van Es

Showing results (71-80 of 153) with videos related to

Pageof 16
Sort By:
Journal of Thrombosis and Haemostasis : JTH|July 13, 2020
Risk scores for occult cancer in patients with unprovoked venous thromboembolism: Results from an individual patient data meta-analysisFrits I Mulder, Marc Carrier, Frederiek van Doormaal, et al.
Thrombosis Research|July 29, 2019
The Ottawa score performs poorly in cancer patients with incidental pulmonary embolismFrits I Mulder, Noémie Kraaijpoel, Marcello Di Nisio, et al.
Thrombosis and Haemostasis|January 6, 2018
Clinical Impact and Course of Anticoagulant-Related Major Bleeding in Cancer PatientsNoémie Kraaijpoel, Nick van Es, Suzanne M Bleker, et al.
Journal of Thrombosis and Haemostasis : JTH|January 27, 2021
Pulmonary embolism at autopsy in cancer patientsInge A Gimbel, Frits I Mulder, Floris T M Bosch, et al.
Thrombosis Research|June 9, 2022
Interrater agreement of two scales on the severity of anticoagulant-related major bleeding in patients with venous thromboembolismNoori A M Guman, Thijs F van Haaps, Nick van Es, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|February 1, 2024
Treatment Patterns of Cancer-associated Thrombosis in the Netherlands: The Four Cities StudyFleur H J Kaptein, Noori A M Guman, Susan B Lohle, et al.
Research and Practice in Thrombosis and Haemostasis|June 22, 2026
Antiphospholipid antibody formation during immune checkpoint inhibition in patients with cancer: a prospective cohort studyAnniek Strijdhorst, Dorien M Salet, Jente M Schoenaker, et al.
JACC. Cardiooncology|June 19, 2025
Risk of Cardiovascular Disease in Cancer Survivors after Systemic Treatment: A Population-Based Cohort StudyFrits I Mulder, Erzsébet Horváth-Puhó, Nick van Es, et al.
Radiology|April 24, 2020
Diagnosis, Prevention, and Treatment of Thromboembolic Complications in COVID-19: Report of the National Institute for Public Health of the NetherlandsMatthijs Oudkerk, Harry R Büller, Dirkjan Kuijpers, et al.
Thrombosis Research|June 3, 2023
Effect of the P-glycoprotein inhibitor tamoxifen on edoxaban plasma levels in women with breast cancerFloris Bosch, Frits Mulder, Linda Franken, et al.
Pageof 16

Showing results (71-80 of 153) with videos related to

Sort By:
Pageof 16
Journal of Thrombosis and Haemostasis : JTH|July 13, 2020
Risk scores for occult cancer in patients with unprovoked venous thromboembolism: Results from an individual patient data meta-analysisFrits I Mulder, Marc Carrier, Frederiek van Doormaal, et al.
Thrombosis Research|July 29, 2019
The Ottawa score performs poorly in cancer patients with incidental pulmonary embolismFrits I Mulder, Noémie Kraaijpoel, Marcello Di Nisio, et al.
Thrombosis and Haemostasis|January 6, 2018
Clinical Impact and Course of Anticoagulant-Related Major Bleeding in Cancer PatientsNoémie Kraaijpoel, Nick van Es, Suzanne M Bleker, et al.
Journal of Thrombosis and Haemostasis : JTH|January 27, 2021
Pulmonary embolism at autopsy in cancer patientsInge A Gimbel, Frits I Mulder, Floris T M Bosch, et al.
Thrombosis Research|June 9, 2022
Interrater agreement of two scales on the severity of anticoagulant-related major bleeding in patients with venous thromboembolismNoori A M Guman, Thijs F van Haaps, Nick van Es, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|February 1, 2024
Treatment Patterns of Cancer-associated Thrombosis in the Netherlands: The Four Cities StudyFleur H J Kaptein, Noori A M Guman, Susan B Lohle, et al.
Research and Practice in Thrombosis and Haemostasis|June 22, 2026
Antiphospholipid antibody formation during immune checkpoint inhibition in patients with cancer: a prospective cohort studyAnniek Strijdhorst, Dorien M Salet, Jente M Schoenaker, et al.
JACC. Cardiooncology|June 19, 2025
Risk of Cardiovascular Disease in Cancer Survivors after Systemic Treatment: A Population-Based Cohort StudyFrits I Mulder, Erzsébet Horváth-Puhó, Nick van Es, et al.
Radiology|April 24, 2020
Diagnosis, Prevention, and Treatment of Thromboembolic Complications in COVID-19: Report of the National Institute for Public Health of the NetherlandsMatthijs Oudkerk, Harry R Büller, Dirkjan Kuijpers, et al.
Thrombosis Research|June 3, 2023
Effect of the P-glycoprotein inhibitor tamoxifen on edoxaban plasma levels in women with breast cancerFloris Bosch, Frits Mulder, Linda Franken, et al.
Pageof 16